END-STAGE LIVER DISEASE

This study tested whether giving growth hormone to people with advanced liver cirrhosis could help them live longer without needing a transplant or having serious complications like fluid buildup or infections. 96 adults with decompensated cirrhosis took part. The goal was to see…

This study looked at whether donated livers that were not perfect (called extended criteria donor livers) could be safely used for transplant after being treated with a special machine that pumps fluids through them. The goal was to see if these livers would work well and last a …

This study looked at whether giving stem cells from umbilical cords more often could help people with end-stage liver disease. 92 adults received infusions through a vein, and researchers checked if multiple infusions worked better than a single one. The goal was to improve liver…

This study tested two approaches to bring palliative care (comfort-focused care) to people with end-stage liver disease. About 1,500 adults from 19 U.S. centers took part. One group had direct access to a palliative care specialist; the other group saw a liver doctor specially tr…

This study tested a short program that teaches liver transplant candidates and a friend or family member how to spread the word about the need for a living donor. 76 people took part. The researchers tracked how many donor inquiries and actual transplants happened within a year.

This study looked at 300 past liver transplant cases to understand why donor livers with fatty liver disease are more likely to be injured after transplant. Researchers used advanced genetic techniques to compare tissue samples from fatty and healthy donor livers. The goal is to …

This study looked at how often patients experience muscle weakness after liver transplant surgery when given a drug called Sugammadex. Researchers used a device on the thumb to measure muscle strength in 97 patients. The goal was to understand recovery better and improve care aft…